“Crossing One Million HCTs and 20,000 CAR-T Treatments”: Inside the 2024 EBMT Activity Report

Driving Visibility in Thalassaemia: The Role of EBMT’s Haemoglobinopathies Working Party

Haemoglobinopathies Working Party Spotlight

EBMT Abstracts at the 2025 ASH Annual Meeting

Haemoglobinopathies Working Party – Registry Data Completion Initiative

EBMT at the 66th ASH Annual Meeting & Exposition

Report of the Cellular Therapies In Non-Malignant Haematology Meeting

EBMT supports the International Thalassaemia Day

Novel curative treatments to cure patients with sickle cell disease and transfusion dependent…